FTC Settles With TruHeight Over Fake Reviews For Kids' Height Pills
Eden Stelmach and Justin Rapoport signed a $4 million judgment, suspended to $750,000 because they could not pay.
- FTC found no competent scientific evidence supported the height-growth claims marketed to children.
- Employees, vendors and discounted customers posted five-star reviews while bots ran fake profiles.
- The order bans unsubstantiated health claims and bans paying for reviews going forward.
Why it matters: Selling parents manufactured trust, bots and paid reviews, instead of evidence, is the whole business model.
FTC Press Release: FTC Approves Final Order Against TruHeight ↗ · Jul 15, 20267/15/26 · ✓ Checked✓ Check